Results 41 to 50 of about 2,905 (197)
Treatment and economic burden of mucormycosis in China: Case report review and burden estimation
The burden estimation of mucormycosis in China shows that drug cost has the highest proportion of total cost (cost/10,000 CNY, type of cost, proportion%). More than 90% of the total cost is direct medical cost, and drug cost is the highest (63.9%) of them followed by inpatient charges during first hospitalization at almost 20%.
Yifei Jian +6 more
wiley +1 more source
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi +8 more
doaj +1 more source
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases
Abstract Biological sex, which comprises differences in host sex hormone homeostasis and immune responses, can have a substantial impact on the epidemiology of infectious diseases. Comprehensive data on sex distributions in invasive fungal diseases (IFDs) are lacking. In this review, we performed a literature search of in vitro/animal studies, clinical
Matthias Egger +4 more
wiley +1 more source
Managing mucormycosis in diabetic patients: A case report with critical review of the literature
Abstract Background and Purpose Rhino–orbito–cerebral mucormycosis (ROCM) is a rare and potentially fatal invasive fungal infection which usually occurs in diabetic and other immunocompromised patients. This infection is associated with high morbidity and mortality rates.
Fabian M. Beiglboeck +6 more
wiley +1 more source
Subcutaneous zygomycosis: A diagnostic and therapeutic challenge
Subcutaneous zygomycosis is a rare deep fungal infection caused by a group of fungus belonging to the order Entomophtharales. It is a saprophytic fungus and the predominant species causing the infection includes Basidiobolus ranarum and Conidiobolus ...
Ketki Chaudhary +4 more
doaj +1 more source
Zygomycosis is a serious and often rapidly fatal infection especially in immunocompromised patients. Rhinocerebral mucormycosis is the most common clinical form, accounting for about 50% of the reported cases. Impaired delivery of the antifungal drugs to
Sushil Kumar Aggarwal, Preeti Agarwal
doaj +1 more source
Introduction: For the best management of the zygomycosis in immunocompromised patients, the present study aims to detect and identify the etiologic agents by DNA sequencing method and their related factors in clinical samples of patients. Methodology:
Parisa Badiee +2 more
doaj +1 more source
Disseminated zygomycosis with involvement of the central nervous system [PDF]
Zygomycosis of the central nervous system (CNS) can manifest in three distinct clinical forms, as rhinocerebral zygomycosis, as disseminated zygomycosis with CNS involvement, and as isolated cerebral zygomycosis.
Prodromou, P. +6 more
core +3 more sources
INTRODUCTION: no comprehensive reports have been published on epidemiological status of Rhinocerebral zygomycosis infections and its outcome in our population, Hence, the current study came to address epidemiological characteristics as well as clinical ...
Vida Bozorgi +5 more
doaj +1 more source
The Rise of an oppurtunistic infection called "Invasive zygomycosis"
Invasive zygomycosis is a devastating fungal infection seen mostly in immune-compromised patients. We present a case of a 48-year old diabetic man, with aplastic anemia, who developed severe pulmonary mucormycosis that led to his rapid demise despite ...
Abdelkarim Waness +2 more
doaj +1 more source

